Liabilities, Current in USD of AbCellera Biologics Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: AbCellera Biologics Inc. quarterly Liabilities, Current history and change rate from Q4 2020 to Q3 2025.
AbCellera Biologics Inc. Liabilities, Current for the quarter ending 30 Sep 2025 was $68.8M, a 13.5% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

AbCellera Biologics Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$68.8M	-$10.8M	-13.5%	30 Sep 2025	10-Q	06 Nov 2025
Q2 2025	$67M	-$3.36M	-4.77%	30 Jun 2025	10-Q	07 Aug 2025
Q1 2025	$75.4M	-$29.5M	-28.1%	31 Mar 2025	10-Q	08 May 2025
Q4 2024	$76.6M	-$42.4M	-35.6%	31 Dec 2024	10-Q	06 Nov 2025
Q3 2024	$79.6M	-$30.7M	-27.8%	30 Sep 2024	10-Q	04 Nov 2024
Q2 2024	$70.4M	-$48.5M	-40.8%	30 Jun 2024	10-Q	06 Aug 2024
Q1 2024	$105M	+$15.3M	+17.1%	31 Mar 2024	10-Q	07 May 2024
Q4 2023	$119M	+$693K	+0.59%	31 Dec 2023	10-K	27 Feb 2025
Q3 2023	$110M	+$4.19M	+3.95%	30 Sep 2023	10-Q	02 Nov 2023
Q2 2023	$119M	-$102M	-46.2%	30 Jun 2023	10-Q	03 Aug 2023
Q1 2023	$89.6M	-$124M	-58%	31 Mar 2023	10-Q	04 May 2023
Q4 2022	$118M	-$2.36M	-1.95%	31 Dec 2022	10-K	20 Feb 2024
Q3 2022	$106M	+$56.5M	+114%	30 Sep 2022	10-Q	08 Nov 2022
Q2 2022	$221M	+$151M	+217%	30 Jun 2022	10-Q	09 Aug 2022
Q1 2022	$213M	+$125M	+141%	31 Mar 2022	10-Q	10 May 2022
Q4 2021	$121M	+$17.2M	+16.6%	31 Dec 2021	10-K	21 Feb 2023
Q3 2021	$49.5M			30 Sep 2021	10-Q	10 Nov 2021
Q2 2021	$69.8M			30 Jun 2021	10-Q	13 Aug 2021
Q1 2021	$88.4M			31 Mar 2021	10-Q	14 May 2021
Q4 2020	$103M			31 Dec 2020	10-K	25 Feb 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.